Advanced

A randomized feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer

Margolin, S; Carlsson, L; Hellström, M; Karlsson, P; Lidbrink, E; Linderholm, B; Lindman, H; Malmström, Per LU ; Sköld Pettersson, D and Bergh, J (2008) EBCC-6, European Breast Cancer Conference, 2008 In European Journal of Cancer Supplements 6(7). p.116-117
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
European Journal of Cancer Supplements
volume
6
issue
7
pages
116 - 117
publisher
Elsevier
conference name
EBCC-6, European Breast Cancer Conference, 2008
external identifiers
  • wos:000256762000252
ISSN
1359-6349
DOI
10.1016/S1359-6349(08)70548-2
language
English
LU publication?
yes
id
e53174a6-c673-43f2-9c01-797a8966fc76 (old id 1191457)
date added to LUP
2008-09-08 16:16:59
date last changed
2016-07-06 15:41:52
@misc{e53174a6-c673-43f2-9c01-797a8966fc76,
  author       = {Margolin, S and Carlsson, L and Hellström, M and Karlsson, P and Lidbrink, E and Linderholm, B and Lindman, H and Malmström, Per and Sköld Pettersson, D and Bergh, J},
  issn         = {1359-6349},
  language     = {eng},
  note         = {Conference Abstract},
  number       = {7},
  pages        = {116--117},
  publisher    = {Elsevier},
  series       = {European Journal of Cancer Supplements},
  title        = {A randomized feasibility/phase II study (SBG 2004-1) with dose-dense/tailored epirubicin, cyclophoshamide (EC) followed by docetaxel (T) or fixed dosed dose-dense EC/T versus T, doxorubicin and C (TAC) in node-positive breast cancer},
  url          = {http://dx.doi.org/10.1016/S1359-6349(08)70548-2},
  volume       = {6},
  year         = {2008},
}